What are the major opportunities in the Major Depressive Disorder market? What are the strategies for the Major Depressive Disorder market?

For detailed insights on the major opportunities and strategies in the Major Depressive Disorder market, Read More

How does the Major Depressive Disorder market relate to the overall economy and other similar markets?

For detailed insights on Major Depressive Disorder's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Major Depressive Disorder market growth? SWOT analysis of the Major Depressive Disorder market.

For detailed insights on the key dynamics influencing the Major Depressive Disorder market growth and SWOT analysis of the Major Depressive Disorder industry, Read More

Major Depressive Disorder Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Major Depressive Disorder Market Report 2026

Name: Major Depressive Disorder Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Treatment (Psychotherapy, Medications, Electroconvulsive Therapy (ECT), Transcranial Magnetic Stimulation (TMS), Other Treatments), By Diagnosis (Psychiatric Evaluations, Diagnostic And Statistical Manual of Mental Disorders (DSM-5)), By End-User (Clinics, Hospitals, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Major Depressive Disorder Market Overview

• Major Depressive Disorder market size has reached to $6.26 billion in 2025

• Expected to grow to $7.49 billion in 2030 at a compound annual growth rate (CAGR) of 3.9%

• Growth Driver: Surge In Substance And Alcohol Abuse Cases Amplifies Growth In Major Depressive Disorder Market

• Market Trend: Next-Generation Digital Therapeutics To Enhance Major Depressive Disorder Treatment Outcomes

• North America was the largest region in 2025.

What Is Covered Under Major Depressive Disorder Market?

Major depressive disorder refers to a mood disorder or depression that causes a persistent feeling of sadness and loss of interest, which can interfere with daily activities such as sleeping, eating, or working. It goes beyond normal fluctuations in mood and can significantly impact a person's thoughts, feelings, behavior and physical well-being. The treatment for major depressive disorder involves several medical interventions that support the emotional well-being of an individual.

The main treatments for major depressive disorder are psychotherapy, medications, electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS) and others. Psychotherapy refers to a therapeutic approach that involves a trained mental health professional helping individuals or groups address emotional, psychological and behavioral issues. It can be diagnosed with physical examinations, laboratory tests, psychiatric evaluations, diagnostic and statistical manual of mental disorders (DSM-5) and others by several end-users including hospitals, clinics and others.

Major Depressive Disorder Market Global Report 2026 Market Report bar graph

What Is The Major Depressive Disorder Market Size and Share 2026?

The major depressive disorder market size has grown steadily in recent years. It will grow from $6.26 billion in 2025 to $6.44 billion in 2026 at a compound annual growth rate (CAGR) of 2.9%. The growth in the historic period can be attributed to increasing prevalence of depressive disorders, growing societal awareness of mental health, wider availability of antidepressant medications, expansion of psychiatric care infrastructure, improved diagnostic guidelines for mood disorders.

What Is The Major Depressive Disorder Market Growth Forecast?

The major depressive disorder market size is expected to see steady growth in the next few years. It will grow to $7.49 billion in 2030 at a compound annual growth rate (CAGR) of 3.9%. The growth in the forecast period can be attributed to rising mental health burden due to lifestyle stress, increasing adoption of digital mental health platforms, growing demand for personalized depression treatments, expansion of insurance coverage for mental health care, continued innovation in neuromodulation therapies. Major trends in the forecast period include rising adoption of combination therapy approaches, growing demand for non-invasive brain stimulation treatments, increasing awareness and diagnosis of depression, expansion of telepsychiatry and remote mental health care, rising acceptance of novel and rapid-acting antidepressants.

Book your 30 minutes free consultation with our research experts

Global Major Depressive Disorder Market Segmentation

1) By Treatment: Psychotherapy, Medications, Electroconvulsive Therapy (ECT), Transcranial Magnetic Stimulation (TMS), Other Treatments

2) By Diagnosis: Psychiatric Evaluations, Diagnostic And Statistical Manual of Mental Disorders (DSM-5)

3) By End-User: Clinics, Hospitals, Other End-Users

Subsegments:

1) By Psychotherapy: Cognitive Behavioral Therapy (CBT), Interpersonal Therapy (IPT), Dialectical Behavior Therapy (DBT), Psychodynamic Therapy

2) By Medications: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs), Tricyclic Antidepressants (TCAs), Monoamine Oxidase Inhibitors (MAOIs), Atypical Antidepressants

3) By Electroconvulsive Therapy (ECT): Unilateral ECT, Bilateral ECT, Modified ECT

4) By Transcranial Magnetic Stimulation (TMS): Repetitive Transcranial Magnetic Stimulation (rTMS), Deep Transcranial Magnetic Stimulation (dTMS), Theta Burst Stimulation (TBS), Navigated Brain Stimulation (nTMS)

5) By Other Treatments: Cognitive Behavioral Therapy (CBT), Psychodynamic Therapy, Interpersonal Therapy (IPT), Vagus Nerve Stimulation (VNS), Ketamine Therapy, Bright Light Therapy, Psychedelic-Assisted Therapy, Medication (Antidepressants)

What Is The Driver Of The Major Depressive Disorder Market?

The rise in cases of substance abuse and alcohol abuse is expected to propel the growth of the major depressive disorder market. Substance and alcohol abuse are terms used to describe patterns of excessive and harmful use of substances, including alcohol, that can lead to negative physical, psychological and social consequences. It commonly co-occurs with major depressive disorder and both conditions tend to feed off each other and significantly increase the risk of physical and mental harm. For instance, in July 2024, according to a survey published by the Substance Abuse and Mental Health Services Administration, a US-based department of health and human services, 3.1% of people (8.9 million) misused opioids in 2023, while 21.8% of individuals aged 12 or older used marijuana, making it the most commonly used illicit drug. Additionally, 9.4% of people aged 12 or older vaped nicotine in the past month, showing an increase from 8.3% in 2022. Therefore, the rise in cases of substance abuse and alcohol abuse is driving the growth of the major depressive disorder industry.

Key Players In The Global Major Depressive Disorder Market

Major companies operating in the major depressive disorder market are Pfizer Inc., Janssen Research and Development LLC, Merck and Co. Inc., Novartis AG, Sanofi-Aventis US LLC, Bristol Myers Squibb Co., AstraZeneca plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Biogen Inc., Otsuka Pharmaceuticals Co. Ltd., Forest Laboratories Inc., H. Lundbeck A/S, Richter Gedeon plc, Allergan plc, Neurocrine Biosciences Inc., BlackThorn Therapeutics Inc., Intra-Cellular Therapies Inc., Axsome Therapeutics Inc., Luye Pharma Group, BrainsWay Ltd., Neumora Therapeutics Inc., Chase Therapeutics Corporation, SAGE Therapeutics Inc., Relmada Therapeutics Inc., Fabre-Kramer Pharmaceuticals Inc., Vistagen Therapeutics Inc.

Global Major Depressive Disorder Market Trends and Insights

Major companies operating in the major depressive disorder (MDD) market are focusing on developing innovative solutions, such as prescription digital therapeutics (PDTs) to meet the rising demand for scalable access to evidence-based psychotherapy, adjunctive treatments for partial responders, and remote, measurement-driven care pathways. Prescription digital therapeutics (PDTs) are software-as-medical-device interventions delivered by prescription that combine clinically validated therapeutic content, remote engagement and adherence tools, and data capture for clinicians; unlike traditional antidepressant medications or in-person psychotherapy, PDTs provide repeatable, standardised, and remotely supervised behavioural interventions that can complement pharmacotherapy or fill gaps where provider access is limited. For instance, in April 2024, Otsuka Pharmaceutical Co., a Japan-based pharmaceutical company, together with Click Therapeutics, launched Rejoyn (developed as CT-152), a prescription digital therapeutic authorised by the U.S. FDA as an adjunctive treatment for adults with MDD who are on antidepressant medication. Rejoyn is a six-week, smartphone-delivered programme built around clinically validated cognitive-emotional brain-training exercises (the Emotional Faces Memory Task/EFMT) and brief therapeutic lessons designed to enhance cognitive control of emotion. The app functions via prescribed delivery, patients download and complete scheduled sessions on their smartphone while clinicians prescribe and monitor usage, and it was studied in the MIRAI randomised, sham-controlled trial showing symptom improvement versus control. Unique features include its neuromodulatory design intended to target neural networks implicated in emotion processing, remote, personalised reminders to boost adherence, and regulatory clearance as a medical device rather than a wellness app.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Major Depressive Disorder Market?

In October 2025, AbbVie Inc., a US-based healthcare and biopharmaceutical company, acquired bretisilocin from Gilgamesh Pharmaceuticals, Inc. for an undisclosed amount. With this acquisition, AbbVie Inc. aims to expand and strengthen its psychiatry and neuroscience pipeline by adding a next-generation, short-acting psychedelic-derived candidate to accelerate development in major depressive disorder. Gilgamesh Pharmaceuticals Inc. is a US-based clinical-stage biotechnology company that specializes in developing novel psychedelic-derived and psychoplastogen therapies, including bretisilocin, a Phase 2 investigational 5-HT2A receptor agonist for moderate-to-severe major depressive disorder.

Regional Outlook

North America was the largest region in the major depressive disorder market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Major Depressive Disorder Market?

The major depressive disorder market consists of revenues earned by entities by providing services such as teletherapy, integrated care, cognitive behavioral therapy, interpersonal therapy, mindfulness-based therapy and residential treatment. The market value includes the value of related goods sold by the service provider or included within the service offering. The major depressive disorder market also includes sales of monoamine oxidase inhibitors, tricyclic antidepressants and mirtazapine. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Major Depressive Disorder Market Report 2026?

The major depressive disorder market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the major depressive disorder industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Major Depressive Disorder Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$6.44 billion
Revenue Forecast In 2035	$7.49 billion
Growth Rate	CAGR of 2.9% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Treatment, Diagnosis, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Pfizer Inc., Janssen Research and Development LLC, Merck and Co. Inc., Novartis AG, Sanofi-Aventis US LLC, Bristol Myers Squibb Co., AstraZeneca plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Biogen Inc., Otsuka Pharmaceuticals Co. Ltd., Forest Laboratories Inc., H. Lundbeck A/S, Richter Gedeon plc, Allergan plc, Neurocrine Biosciences Inc., BlackThorn Therapeutics Inc., Intra-Cellular Therapies Inc., Axsome Therapeutics Inc., Luye Pharma Group, BrainsWay Ltd., Neumora Therapeutics Inc., Chase Therapeutics Corporation, SAGE Therapeutics Inc., Relmada Therapeutics Inc., Fabre-Kramer Pharmaceuticals Inc., Vistagen Therapeutics Inc.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Major Depressive Disorder Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Major Depressive Disorder Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Major Depressive Disorder Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Major Depressive Disorder Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Artificial Intelligence & Autonomous Intelligence

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Biotechnology, Genomics & Precision Medicine

4.1.4 Immersive Technologies (Ar/Vr/Xr) & Digital Experiences

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Adoption Of Combination Therapy Approaches

4.2.2 Growing Demand For Non-Invasive Brain Stimulation Treatments

4.2.3 Increasing Awareness And Diagnosis Of Depression

4.2.4 Expansion Of Telepsychiatry And Remote Mental Health Care

4.2.5 Rising Acceptance Of Novel And Rapid-Acting Antidepressants

5. Major Depressive Disorder Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Psychiatric Clinics

5.3 Mental Health Centers

5.4 Rehabilitation Centers

5.5 Home Healthcare Providers

6. Major Depressive Disorder Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Major Depressive Disorder Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Major Depressive Disorder PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Major Depressive Disorder Market Size, Comparisons And Growth Rate Analysis

7.3. Global Major Depressive Disorder Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Major Depressive Disorder Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Major Depressive Disorder Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Major Depressive Disorder Market Segmentation

9.1. Global Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Psychotherapy, Medications, Electroconvulsive Therapy (ECT), Transcranial Magnetic Stimulation (TMS), Other Treatments

9.2. Global Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Psychiatric Evaluations, Diagnostic And Statistical Manual of Mental Disorders (DSM-5)

9.3. Global Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Clinics, Hospitals, Other End-Users

9.4. Global Major Depressive Disorder Market, Sub-Segmentation Of Psychotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cognitive Behavioral Therapy (CBT), Interpersonal Therapy (IPT), Dialectical Behavior Therapy (DBT), Psychodynamic Therapy

9.5. Global Major Depressive Disorder Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs), Tricyclic Antidepressants (TCAs), Monoamine Oxidase Inhibitors (MAOIs), Atypical Antidepressants

9.6. Global Major Depressive Disorder Market, Sub-Segmentation Of Electroconvulsive Therapy (ECT), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Unilateral ECT, Bilateral ECT, Modified ECT

9.7. Global Major Depressive Disorder Market, Sub-Segmentation Of Transcranial Magnetic Stimulation (TMS), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Repetitive Transcranial Magnetic Stimulation (rTMS), Deep Transcranial Magnetic Stimulation (dTMS), Theta Burst Stimulation (TBS), Navigated Brain Stimulation (nTMS)

9.8. Global Major Depressive Disorder Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cognitive Behavioral Therapy (CBT), Psychodynamic Therapy, Interpersonal Therapy (IPT), Vagus Nerve Stimulation (VNS), Ketamine Therapy, Bright Light Therapy, Psychedelic-Assisted Therapy, Medication (Antidepressants)

10. Major Depressive Disorder Market Regional And Country Analysis

10.1. Global Major Depressive Disorder Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Major Depressive Disorder Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Major Depressive Disorder Market

11.1. Asia-Pacific Major Depressive Disorder Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Major Depressive Disorder Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Major Depressive Disorder Market

12.1. China Major Depressive Disorder Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Major Depressive Disorder Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Major Depressive Disorder Market

13.1. India Major Depressive Disorder Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Major Depressive Disorder Market

14.1. Japan Major Depressive Disorder Market Overview

14.2. Japan Major Depressive Disorder Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Major Depressive Disorder Market

15.1. Australia Major Depressive Disorder Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Major Depressive Disorder Market

16.1. Indonesia Major Depressive Disorder Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Major Depressive Disorder Market

17.1. South Korea Major Depressive Disorder Market Overview

17.2. South Korea Major Depressive Disorder Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Major Depressive Disorder Market

18.1. Taiwan Major Depressive Disorder Market Overview

18.2. Taiwan Major Depressive Disorder Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Major Depressive Disorder Market

19.1. South East Asia Major Depressive Disorder Market Overview

19.2. South East Asia Major Depressive Disorder Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Major Depressive Disorder Market

20.1. Western Europe Major Depressive Disorder Market Overview

20.2. Western Europe Major Depressive Disorder Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Major Depressive Disorder Market

21.1. UK Major Depressive Disorder Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Major Depressive Disorder Market

22.1. Germany Major Depressive Disorder Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Major Depressive Disorder Market

23.1. France Major Depressive Disorder Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Major Depressive Disorder Market

24.1. Italy Major Depressive Disorder Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Major Depressive Disorder Market

25.1. Spain Major Depressive Disorder Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Major Depressive Disorder Market

26.1. Eastern Europe Major Depressive Disorder Market Overview

26.2. Eastern Europe Major Depressive Disorder Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Major Depressive Disorder Market

27.1. Russia Major Depressive Disorder Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Major Depressive Disorder Market

28.1. North America Major Depressive Disorder Market Overview

28.2. North America Major Depressive Disorder Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Major Depressive Disorder Market

29.1. USA Major Depressive Disorder Market Overview

29.2. USA Major Depressive Disorder Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Major Depressive Disorder Market

30.1. Canada Major Depressive Disorder Market Overview

30.2. Canada Major Depressive Disorder Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Major Depressive Disorder Market

31.1. South America Major Depressive Disorder Market Overview

31.2. South America Major Depressive Disorder Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Major Depressive Disorder Market

32.1. Brazil Major Depressive Disorder Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Major Depressive Disorder Market

33.1. Middle East Major Depressive Disorder Market Overview

33.2. Middle East Major Depressive Disorder Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Major Depressive Disorder Market

34.1. Africa Major Depressive Disorder Market Overview

34.2. Africa Major Depressive Disorder Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Major Depressive Disorder Market Regulatory and Investment Landscape

36. Major Depressive Disorder Market Competitive Landscape And Company Profiles

36.1. Major Depressive Disorder Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Major Depressive Disorder Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Major Depressive Disorder Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Janssen Research and Development LLC Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Sanofi-Aventis US LLC Overview, Products and Services, Strategy and Financial Analysis

37. Major Depressive Disorder Market Other Major And Innovative Companies

Bristol Myers Squibb Co., AstraZeneca plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Biogen Inc., Otsuka Pharmaceuticals Co. Ltd., Forest Laboratories Inc., H. Lundbeck A/S, Richter Gedeon plc, Allergan plc, Neurocrine Biosciences Inc., BlackThorn Therapeutics Inc., Intra-Cellular Therapies Inc., Axsome Therapeutics Inc.

38. Global Major Depressive Disorder Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Major Depressive Disorder Market

40. Major Depressive Disorder Market High Potential Countries, Segments and Strategies

40.1 Major Depressive Disorder Market In 2030 - Countries Offering Most New Opportunities

40.2 Major Depressive Disorder Market In 2030 - Segments Offering Most New Opportunities

40.3 Major Depressive Disorder Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Major Depressive Disorder Market, Overview Of Key Products - Product Examples

Table 2: Global Major Depressive Disorder Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Major Depressive Disorder Market, Supply Chain Analysis

Table 4: Global Major Depressive Disorder Market, Major Raw Material Providers

Table 5: Global Major Depressive Disorder Market, Major Resource Providers

Table 6: Global Major Depressive Disorder Market, Major Manufacturers (Suppliers)

Table 7: Global Major Depressive Disorder Market, Major Distributors And Channel Partners

Table 8: Global Major Depressive Disorder Market, Key Technologies & Future Trends

Table 9: Global Major Depressive Disorder Market, Major Trends

Table 10: Global Major Depressive Disorder Market, Major End Users

Table 11: Global Major Depressive Disorder Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Major Depressive Disorder Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Major Depressive Disorder Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Major Depressive Disorder Market - TAM, US$ Billion, 2025

Table 15: Global Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Major Depressive Disorder Market, Sub-Segmentation Of Psychotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Major Depressive Disorder Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Major Depressive Disorder Market, Sub-Segmentation Of Electroconvulsive Therapy (ECT), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Major Depressive Disorder Market, Sub-Segmentation Of Transcranial Magnetic Stimulation (TMS), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Major Depressive Disorder Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Major Depressive Disorder Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Major Depressive Disorder Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Global Major Depressive Disorder Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 98: Global Major Depressive Disorder Market - Company Scoring Matrix

Table 99: Pfizer Inc. Financial Performance

Table 100: Janssen Research and Development LLC Financial Performance

Table 101: Merck and Co. Inc. Financial Performance

Table 102: Novartis AG Financial Performance

Table 103: Sanofi-Aventis US LLC Financial Performance

Table 104: Global Major Depressive Disorder Market, Competitive Benchmarking (In USD Billions)

Table 105: Global Major Depressive Disorder Market, Competitive Dashboard

Table 106: Global Major Depressive Disorder Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 107: Global, Major Depressive Disorder Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030

Table 108: Global, Major Depressive Disorder Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030

Table 109: Global, Major Depressive Disorder Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

List Of Figures

Figure 1: Global Major Depressive Disorder Market, Overview Of Key Products - Product Examples

Figure 2: Global Major Depressive Disorder Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Major Depressive Disorder Market, Supply Chain Analysis

Figure 4: Global Major Depressive Disorder Market, Major Raw Material Providers

Figure 5: Global Major Depressive Disorder Market, Major Resource Providers

Figure 6: Global Major Depressive Disorder Market, Major Manufacturers (Suppliers)

Figure 7: Global Major Depressive Disorder Market, Major Distributors And Channel Partners

Figure 8: Global Major Depressive Disorder Market, Key Technologies & Future Trends

Figure 9: Global Major Depressive Disorder Market, Major Trends

Figure 10: Global Major Depressive Disorder Market, Major End Users

Figure 11: Global Major Depressive Disorder Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Major Depressive Disorder Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Major Depressive Disorder Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Major Depressive Disorder Market - TAM, US$ Billion, 2025

Figure 15: Global Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Major Depressive Disorder Market, Sub-Segmentation Of Psychotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Major Depressive Disorder Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Major Depressive Disorder Market, Sub-Segmentation Of Electroconvulsive Therapy (ECT), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Major Depressive Disorder Market, Sub-Segmentation Of Transcranial Magnetic Stimulation (TMS), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Major Depressive Disorder Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Major Depressive Disorder Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Major Depressive Disorder Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Major Depressive Disorder Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Major Depressive Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Major Depressive Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Global Major Depressive Disorder Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 98: Global Major Depressive Disorder Market - Company Scoring Matrix

Figure 99: Pfizer Inc. Financial Performance

Figure 100: Janssen Research and Development LLC Financial Performance

Figure 101: Merck and Co. Inc. Financial Performance

Figure 102: Novartis AG Financial Performance

Figure 103: Sanofi-Aventis US LLC Financial Performance

Figure 104: Global Major Depressive Disorder Market, Competitive Benchmarking (In USD Billions)

Figure 105: Global Major Depressive Disorder Market, Competitive Dashboard

Figure 106: Global Major Depressive Disorder Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 107: Global, Major Depressive Disorder Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030

Figure 108: Global, Major Depressive Disorder Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030

Figure 109: Global, Major Depressive Disorder Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

Strategic Report on Gender Reassignment Surgery Market: Growth Opportunities and Emerging Challenges

In-Depth Health Check-Up Market Report: Business Trends, Growth Factors, and Forecast to 2029

Global Insights: Healthcare Digital Experience Platform Market Expected to Surpass $4.34 Billion by 2029

2025 Healthcare Information Technology (IT) Outsourcing Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Explore the latest trends, growth insights, and forecasts in the Nutrition Analysis Software Global Market.

Explore the latest trends, growth insights, and forecasts in the Global Wearable Fitness Trackers Market.

Generalized Anxiety Disorder Market Report 2026 - Global Outlook – By Type (Panic Disorder, Agoraphobia, Generalized Anxiety, Social Anxiety, Specific Phobia, Other Types), By Therapies (Interpersonal Therapy, Behavior T...

Antidepressants Market Report 2026 - Global Outlook – By Product (Selective Serotonin Reuptake Inhibitor (SSRI), Serotonin-norepinephrine Reuptake Inhibitor (SNRI), Tricyclic Antidepressant (TCA), Monoamine Oxidase Inhib...

Panic Disorders Market Report 2026 - Global Outlook – By Treatment Type (Pharmacotherapies, Psychotherapeutic Interventions, Digital Or Tech-Enabled Therapies), By Disorder Type (Panic Disorder Without Agoraphobia, Panic...

Mental Health Market Report 2026 - Global Outlook – By Disorder (Schizophrenia, Alcohol Use Disorders, Bipolar Disorder, Depression, Anxiety, Post-Traumatic Stress Disorder, Substance Abuse Disorders, Eating Disorders, O...

Postpartum Depression Market Report 2026 - Global Outlook – By Types (Postpartum Blues, Postpartum Anxiety, Postpartum Obsessive Compulsive Disorder, Postpartum Panic Disorder, Postpartum Post-Traumatic Stress Disorder, ...

Behavioral Therapy Market Report 2026 - Global Outlook – By Type (Cognitive Behavioral Therapy, Systematic Desensitization, Cognitive Behavioral Play Therapy, Other Types), By Treatment Settings (Hospitals, Community Hea...

Post-Traumatic Stress Disorder Therapeutics Market Report 2026 - Global Outlook – By Drug Class (Antidepressants, Anti-Anxiety, Antihypertensive, Antipsychotics Or Second Generation Antipsychotics (SGOs), Beta-Blockers, ...

Frequently Asked Questions

How big is the Major Depressive Disorder Market?

The Major Depressive Disorder market was valued at $6.26 billion in 2025, increased to $6.44 billion in 2026, and is projected to reach $7.49 billion by 2030. request a sample here

What is the Major Depressive Disorder market growth?

The global Major Depressive Disorder market is expected to grow at a CAGR of 3.9% from 2026 to 2035 to reach $7.49 billion by 2035. request a sample here

Who are the key players in Major Depressive Disorder market?

Some Key Players in the Major Depressive Disorder market Include, Pfizer Inc., Janssen Research and Development LLC, Merck and Co. Inc., Novartis AG, Sanofi-Aventis US LLC, Bristol Myers Squibb Co., AstraZeneca plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Biogen Inc., Otsuka Pharmaceuticals Co. Ltd., Forest Laboratories Inc., H. Lundbeck A/S, Richter Gedeon plc, Allergan plc, Neurocrine Biosciences Inc., BlackThorn Therapeutics Inc., Intra-Cellular Therapies Inc., Axsome Therapeutics Inc., Luye Pharma Group, BrainsWay Ltd., Neumora Therapeutics Inc., Chase Therapeutics Corporation, SAGE Therapeutics Inc., Relmada Therapeutics Inc., Fabre-Kramer Pharmaceuticals Inc., Vistagen Therapeutics Inc. . request a sample here

What is the anticipated growth trend for the Major Depressive Disorder market?

Major trend in this market includes: Next-Generation Digital Therapeutics To Enhance Major Depressive Disorder Treatment Outcomes. For further insights on this market. request a sample here

Which region has the most growth potential in the Major Depressive Disorder market?

North America was the largest region in the major depressive disorder market in 2025. The regions covered in the major depressive disorder market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Who are the key players in the Major Depressive Disorder Market Report 2026 market?

Major companies operating in the Major Depressive Disorder Market Report 2026 market are Major companies operating in the major depressive disorder market are Pfizer Inc., Janssen Research and Development LLC, Merck and Co. Inc., Novartis AG, Sanofi-Aventis US LLC, Bristol Myers Squibb Co., AstraZeneca plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Biogen Inc., Otsuka Pharmaceuticals Co. Ltd., Forest Laboratories Inc., H. Lundbeck A/S, Richter Gedeon plc, Allergan plc, Neurocrine Biosciences Inc., BlackThorn Therapeutics Inc., Intra-Cellular Therapies Inc., Axsome Therapeutics Inc., Luye Pharma Group, BrainsWay Ltd., Neumora Therapeutics Inc., Chase Therapeutics Corporation, SAGE Therapeutics Inc., Relmada Therapeutics Inc., Fabre-Kramer Pharmaceuticals Inc., Vistagen Therapeutics Inc. request a sample here.

Which region has the most growth potential in the Major Depressive Disorder Market Report 2026 market?